Year : 2015 | Volume
: 141 | Issue : 6 | Page : 753--756
Yoga- a potential solution for diabetes & metabolic syndrome
Dukhabandhu Naik, Nihal Thomas
Department of Endocrinology, Diabetes & Metabolism, Christian Medical College,Vellore 632 004, Tamil Nadu, India
Department of Endocrinology, Diabetes & Metabolism, Christian Medical College,Vellore 632 004, Tamil Nadu
|How to cite this article:|
Naik D, Thomas N. Yoga- a potential solution for diabetes & metabolic syndrome.Indian J Med Res 2015;141:753-756
|How to cite this URL:|
Naik D, Thomas N. Yoga- a potential solution for diabetes & metabolic syndrome. Indian J Med Res [serial online] 2015 [cited 2021 Apr 22 ];141:753-756
Available from: https://www.ijmr.org.in/text.asp?2015/141/6/753/160689
India accounts for almost 70 million people with diabetes and the number is expected to increase to 90 million by the year 2030  . Over the last few decades, the mean age of onset of diabetes has been on the decline, the disorder thereby affects a relatively younger segment of the population  . Genetic predisposition and environmental factors like physical inactivity, excessive calorie intake and obesity, low birth weight and genetic factors play an important role in the evolution of diabetes , . Visceral adiposity produces several inflammatory cytokines like tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), resistin and vistafin which are associated with insulin resistance and the metabolic syndrome .
Vitamin D deficiency has been found to be more common among those with prediabetes, diabetes and obesity. The lowered serum circulating vitamin D levels are inversely associated with severity of insulin resistance  . Vitamin D supplementation has shown to prevent the development of new onset diabetes thereby improving the insulin sensitivity and glycaemic control  .
Large clinical studies like the United Kingdom Prospective Diabetes Study (UKPDS)  , Diabetes Control and Complications Trial Research Group (DCCT)  and the Kumamoto study  have demonstrated that intensive glycaemic control can significantly reduce microvascular complications, however, may fail to have an impact on reduction of macrovascular complications. The rapid increase in incidence of diabetes and the challenges faced by healthcare givers to provide high quality care to all persons with diabetes related complications and growing economic and personal cost of the treatment of disease are indeed compelling for the need of primary prevention in type 2 diabetes  .
A strategy of primary prevention may be focused on high risk individuals who are prone for the development of diabetes. Lifestyle modifications (LSM) include enhanced physical activity, dietary modification, weight loss and behavioural modifications. Several studies such as the Finnish diabetes prevention study (DPS)  , the Diabetes prevention program (DPP) in the United States of America  , the Indian Diabetes Prevention Programme (IDPP) , and the Chinese Da Qing study have demonstrated the efficacy and benefits of life style interventions  . Pharmacological interventions with drugs like metformin, rosiglitazone, acarbose and orlistat have been studied in high risk individuals and were also proven to be effective ,, .
Lifestyle modification (LSM) is from a pragmatic perspective, considered to be the primary line of intervention prior to any pharmacological therapy for preventing the development of diabetes in high risk individuals  . Moreover, cohort studies like the 7-year project that was involved in the Finnish DPS and the
20 year follow up that was accomplished in the Da Qing Study, had established that the beneficial effects of lifestyle intervention were sustainable , .
The modern form of yoga is primarily focused on simple physical exercises (asanās), breathing exercise (prānayāma), followed by relaxation techniques (shāvasāna) or meditation. Yoga has been considered as a simple and potentially economical therapy that may be used alongside medical treatment of diabetes. The benefits of yoga have been studied based on various aspects of diabetes such as glycaemic control, quality of life and on several complications of diabetes. In a systemic review Innes et al[22 ] have [ ] analyzed 70 previous studies on the effect of yoga and suggested that yoga may reduce the insulin resistance related risks in relation to cardiovascular disease. Another study has prospectively evaluated the benefit of yoga on glycaemic control and the quality of life of subjects with type 2 diabetes for a period of three months  . All participants in the study had previously been on lifestyle modification (diet and exercise) and on oral medications. There was a significant improvement in the quality of life in the yogic group and only a marginal impact on glycaemic control  . A study by Amita et al assessed the effect of yoga nidrāā for three months among middle aged patients with diabetes on oral medications. The study group was randomized into those on yoga group and a control group on simple lifestyle measures. There was an improvement in symptom score, reduction of fasting blood glucose (22.75 mg/dl) and postprandial blood glucose by
18 mg/dl, both of which were significant when compared with the control group  . The effect of yoga has also been studied in patients with gestational diabetes mellitus (GDM). The patients with GDM were randomized into those on yoga and mindful eating, and a control group for eight weeks. The difference in the mean fasting blood glucose, postprandial blood glucose and mean HbA1c levels between the two groups was significant, however, the clinical differences were rather small  . Singh et al studied the 40 day effect of yoga on glycaemic control and autonomic function in patients with diabetes. There was a marked improvement in the glycaemic profile inclusive of fasting blood glucose, postprandial blood glucose and HbA1c levels when compared with the baseline status. A positive impact was also noticed on various autonomic indices such as the pulse, blood pressure and corrected QT interval  . Manjunatha et al studied the beneficial effect of yogic postures on blood glucose control. In another study an improvement of glycaemic control and pulmonary function in type 2 diabetes patients was seen with yoga asanas . Singh et al in a preliminary study, validated the efficacy of yoga in glycaemic control and on reducing the markers of oxidative stress: serum malondialdehyde (MDA). Malhotra et al conducted a randomized controlled study and demonstrated the beneficial effect on glycaemic control and nerve conduction after 40 days of yoga. A short study of 10 days showed the effect of yoga in improving lipid profile and glycaemic parameters  . Yoga practice has also been shown to reduce anxiety and may improve overall wellbeing along with reduction in BMI  .
In this issue Netam et al have demonstrated beneficial effects of short-term yoga-based lifestyle intervention programme on diabetes risk factors in obese individuals. The study included supervised yoga intervention for 10 days and a follow up at 30 days. At day 10 a significant reduction was observed in body weight, BMI, waist-hip ratio, blood glucose level and median fasting insulin and interleukin-6 (IL-6). This study also highlighted the challenges in sustainability of this intervention during the follow up period. McDermott et al did a pilot study to look at the effect of yoga in individuals at a high risk for diabetes. Each yoga session lasted for 75 min. The study group showed a significant weight loss, reduction in waist circumference and an improvement in psychological well being.
Kanayan et al
in the PRYSMS study, randomized patients into a yoga group and stretching group for 48 wk. At six months of follow up, the yoga group had a reduction in the levels of fasting blood glucose, HbA1c, low density lipoprotein cholesterol and increase in HDL- C. However, at the end of 12 months, there was no sustained change except for a drop in fasting blood sugar. In a community based study, Hegde et al evaluated the effect of yoga on oxidative stress in prediabetes patients. At the end of three months, yoga was associated with reduction in malondialdehyde, a marker of oxidative stress. A similar study showed that short-term yoga for 10 days reduced the IL-6 level and increased the adiponectin level  . Yoga was shown to be effective in reducing the waist circumference, blood pressure and improving the lipid and glycaemic profiles in metabolic syndrome  . A study from Korea was conducted on boys with obesity for a period of eight weeks. It was found that yoga could significantly reduce the body weight, BMI, fat mass (FM) and body fat percentage and improve fat free mass and the basal metabolic rate  .
In summary, short-term studies on yoga have been found to be moderately effective in reducing various risk factors of prediabetes, obesity and the metabolic syndrome. Studies have shown a beneficial impact on achieving glycaemic control in type 2 diabetes and gestational diabetes mellitus. However, there was heterogeneity in the methodology and the sample sizes across the various studies. In majority of these studies, the sample size was small and the duration of the studies was short. There was also a variability in the pattern of yoga, type of yoga and timing of individual sessions among all studies.
There is a need for proper randomized controlled interventions with adequate sample size and power with an appropriate duration. The effect of yoga also has to be studied across various ethnic populations and risk categories to identify which pattern of yoga is more beneficial and which disorders benefit best from yogic interventions. It is also essential to have a trained expert yoga instructor, to design and individualize the yoga to maximize the benefit when yoga is advised for therapeutic purposes.
|1||Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 : 1047-53.|
|2||Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M; Consensus Workshop Group. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004; 27 : 1798-811.|
|3||Thomas N, Grunnet LG, Poulsen P, Christopher S, Spurgeon R, Inbakumari M, et al. Born with low birth weight in rural Southern India: what are the metabolic consequences 20 years later? Eur J Endocrinol 2012; 166 : 647-55. |
|4||Chapla A, Mruthyunjaya MD, Asha HS, Varghese D, Varshney M, Vasan SK, et al. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing. Clin Endocrinol (Oxf) 2015; 82 : 533-42.|
|5||Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9 : 367-77. |
|6||Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res 2013; 138 : 853-60. |
|7||Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 2014; 57 : 2038-47.|
|8||The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352 : 837-53.|
|9||The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329 : 977-86.|
|10||Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28 : 103-17.|
|11||Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 2007; 30 : 2548-52. |
|12||Lindstr¨om J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368 : 1673-9.|
|13||Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med 2002; 346 : 393-403.|
|14||Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49 : 289-97.|
|15||Li G, Hu Y, Yang W, Jiang Y, Wang J, Xiao J, et al. Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study. Diabetes Res Clin Pract 2002; 58 : 193-200.|
|16||Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Investigators. Effect of Rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomized controlled trial. Lancet 2006; 368 : 1096-105.|
|17||Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: The STOPNIDDM randomised trial. Lancet 2002; 359 : 2072-7.|
|18||Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27 : 155-61.|
|19||Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344 : 1343-50. |
|20||Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368 : 1673-9. |
|21||Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371 : 1783-9. |
|22||Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract 2005; 18 : 491-519. |
|23||Jyotsna VP, Joshi A, Ambekar S, Kumar N, Dhawan A, Sreenivas V. Comprehensive yogic breathing program improves quality of life in patients with diabetes. Indian J Endocrinol Metab 2012; 16 : 423-8. |
|24||Amita S, Prabhakar S, Manoj I, Harminder S, Pavan T. Effect of yoga-nidra on blood glucose level in diabetic patients. Indian J Physiol Pharmacol 2009; 53 : 97-101. |
|25||Youngwanichsetha S, Phumdoung S, Ingkathawornwong T. The effects of mindfulness eating and yoga exercise on blood sugar levels of pregnant women with gestational diabetes mellitus. Appl Nurs Res 2014; 27 : 227-30.|
|26||Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India 2004; 52 : 203-6. |
|27||Manjunatha S, Vempati RP, Ghosh D, Bijlani RL. An investigation into the acute and long-term effects of selected yogic postures on fasting and postprandial glycemia and insulinemia in healthy young subjects. Indian J Physiol Pharmacol 2005; 49 : 319-24. |
|28||Malhotra V, Singh S, Singh KP, Gupta P, Sharma SB, Madhu SV, et al. Study of yoga asanas in assessment of pulmonary function in NIDDM patients. Indian J Physiol Pharmacol 2002; 46 : 313-20. |
|29||Singh S, Malhotra V, Singh KP, Sharma SB, Madhu SV, Tandon OP. A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependent diabetes mellitus. Indian J Clin Biochem 2001; 16 : 216-20. |
|30||Malhotra V, Singh S, Tandon OP, Madhu SV, Prasad A, Sharma SB. Effect of Yoga asanas on nerve conduction in type 2 diabetes. Indian J Physiol Pharmacol 2002; 46 : 298-306. |
|31||Bijlani RL, Vempati RP, Yadav RK, Ray RB, Gupta V, Sharma R, et al. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Altern Complement Med 2005; 11 : 267-74. |
|32||Kosuri M, Sridhar GR. Yoga practice in diabetes improves physical and psychological outcomes. Metab Syndr Relat Disord 2009; 7 : 515-7. |
|33||Netam R, Yadav RK, Khadgawat R, Sarvottam K, Yadav R. Interleukin-6, vitamin D & diabetes risk factors modified by a short-term yoga-based lifestyle intervention in overweight/obese individuals. Indian J Med Res 2015; 141 : 775-82.|
|34||McDermott KA, Rao MR, Nagarathna R, Murphy EJ, Burke A, Nagendra RH, et al. A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial. BMC Complement Altern Med 2014; 14 : 212. |
|35||Kanaya AM, Araneta MR, Pawlowsky SB, Barrett-Connor E, Grady D, Vittinghoff E, et al. Restorative yoga and metabolic risk factors: the Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) randomized trial. J Diabetes Complications 2014; 28 : 406-12. |
|36||Hegde SV, Adhikari P, Shetty S, Manjrekar P, D'Souza V. Effect of community-based yoga intervention on oxidative stress and glycemic parameters in prediabetes: a randomized controlled trial. Complement Ther Med 2013; 21 : 571-6. |
|37||Sarvottam K, Magan D, Yadav RK, Mehta N, Mahapatra SC. Adiponectin, interleukin-6, and cardiovascular disease risk factors are modified by a short-term yoga-based lifestyle intervention in overweight and obese men. J Altern Complement Med 2013; 19 : 397-402. |
|38||Khatri D, Mathur KC, Gahlot S, Jain S, Agrawal RP. Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome. Diabetes Res Clin Pract 2007; 78 : e9-10. |
|39||Seo DY, Lee S, Figueroa A, Kim HK, Baek YH, Kwak YS, et al. Yoga training improves metabolic parameters in obese boys. Korean J Physiol Pharmacol 2012; 16 : 175-80.|